glp 1 reduce cancer risk If you are taking a GLP-1 for diabetes or weight loss, a new study found it may also be lowering your of colon cancer. Researchers analyzed health records for 281,000 people Do GLP-1s Lower Cancer Risk?

Side effects like nausea are common initially but often improve

Users who have been on semaglutide long-term or those considering maintaining results after tirzepatide should view dry mouth management as an evolving practice rather than a one-time fix

Compared with the single vaccine group, mice vaccinated with protein/DNA complexes can secrete higher levels of IFN- and IL-4

Gq-mER is present in the hypothalamus and its expression is restricted to NPY/AgRP neurons where it decreases neuronal activity (82, 83, 92)

The Science Behind GHK Cu Peptide in Skin Biology Research A lot of the interest in this molecule comes down to one question: How does it talk to cells

Participants Patients would be eligible for this study if they fulfilled the following criteria: (1) diagnosed with T2DM within the past 12 months according to 1999 WHO criteria, (2) without oral antidiabetic agents or short-term (i.e., 1 month) treatment discontinued 3 months before enrollment, and (3) suboptimum glucose control (HbA1c between 7.0% and 10.0%, FPG 111 mmol/L, and BMI 1930 kg/m 2 )